Fengxia Xiao
107 Wenhuaxi Road
Jinan, China
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Rhoifolin improves bleomycin-induced fibrosis in vivo and cell damage in vitro both related to NRF2/HO-1 pathway.
Journal: BMC pulmonary medicine
Published: November 02, 2023
Pathogenic variants in human DNA damage repair genes mostly arose in recent human history.
Journal: BMC cancer
Published: September 21, 2023
Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes.
Journal: Human genomics
Published: May 27, 2023
Evolutionary Origin of MUTYH Germline Pathogenic Variations in Modern Humans.
Journal: Biomolecules
Published: December 07, 2022
Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population.
Journal: International journal of cancer
Published: September 22, 2022
Elevated β-catenin and C-myc promote malignancy, relapse, and indicate poor prognosis in patients with relapsed glioma.
Journal: Journal of cancer research and therapeutics
Published: June 01, 2022
Rhoifolin Alleviates Alcoholic Liver Disease In Vivo and In Vitro via Inhibition of the TLR4/NF-κB Signaling Pathway.
Journal: Frontiers in pharmacology
Published: February 18, 2022
Retraction: Overexpression of HDAC8 and down-regulation of CDKN2A is associated with worse prognosis of esophageal squamous cell carcinoma.
Journal: Translational cancer research
Published: June 10, 2021
Rhoifolin Alleviates Inflammation of Acute Inflammation Animal Models and LPS-Induced RAW264.7 Cells via IKKβ/NF-κB Signaling Pathway.
Journal: Inflammation
Published: July 04, 2020
Over-expression of HDAC8 down-regulate CDKN2A is associated with worse prognosis of esophageal squamous cell carcinoma.
Journal: Translational cancer research
Published: November 02, 2019
Last Updated: 09/26/2026